MSL
PTCT icon

Mackay Shields LLC’s PTC Therapeutics PTCT Stock Holding History

Mackay Shields LLC’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-24,227
Closed -$1.15M – 1174
2021
Q1 		$1.15M Sell
24,227
-14,883
-38% -$884K 0.01% 956
2020
Q4 		$2.39M Sell
39,110
-5,200
-12% -$306K 0.02% 788
2020
Q3 		$2.07M Sell
44,310
-2,300
-5% -$113K 0.01% 776
2020
Q2 		$2.37M Sell
46,610
-1,300
-3% -$63.9K 0.02% 677
2020
Q1 		$2.14M Buy
47,910
+1,700
+4% +$85.6K 0.02% 640
2019
Q4 		$2.22M Sell
46,210
-3,400
-7% -$144K 0.02% 836
2019
Q3 		$1.68M Buy
49,610
+1,300
+3% +$56.6K 0.01% 969
2019
Q2 		$2.17M Buy
48,310
+31,983
+196% +$1.26M 0.01% 866
2019
Q1 		$614K Buy
16,327
+200
+1% +$6.71K ﹤0.01% 1135
2018
Q4 		$554K Sell
16,127
-1,673
-9% -$60.2K ﹤0.01% 1114
2018
Q3 		$837K Sell
17,800
-500
-3% -$20.7K 0.01% 917
2018
Q2 		$618K Buy
+18,300
New +$571K ﹤0.01% 1051

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Mackay Shields LLC's PTCT Position: Q2 2021 in Review

Mackay Shields LLC sold out of PTC Therapeutics (PTCT) in Q2 2021, closing a stake of 24,227 shares — an estimated $1.15M sold.

Mackay Shields LLC first reported a position in PTCT in Q2 2018 and held it in 12 quarters. The position peaked at $2.39M in Q4 2020. 182 funds tracked by Wall St. Rank hold PTCT as of Q2 2021.

  • Mackay Shields LLC reported no remaining PTC Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 24,227 PTC Therapeutics shares in Q2 2021, an estimated $1.15M.
  • Mackay Shields LLC first reported a position in PTC Therapeutics in Q2 2018 and held it in 12 quarters.
  • Mackay Shields LLC's PTC Therapeutics position peaked at $2.39M in Q4 2020.
  • 182 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.